Kaisa Health proposes renaming to Qinghai Biotech Pharmaceutical Group

PUBT · 1d ago
Kaisa Health proposes renaming to Qinghai Biotech Pharmaceutical Group
  • Kaisa Health Group Holdings plans to rebrand as Qinghai Biotech Pharmaceutical Group, adopting the Chinese secondary name 青海生物製藥集團有限公司.
  • Shareholders will vote on the revised name change at a special general meeting set for Sept. 1, 2026.
  • The earlier meeting was postponed indefinitely; the share register will close Aug. 27 to Sept. 1, 2026 for meeting eligibility.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Health Group Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260806-12276377), on August 06, 2026, and is solely responsible for the information contained therein.